Erythropoietin

As per available reports about 1486 journals, 7 Conferences are presently dedicated exclusively to Erythropoietin and about 33723 articles are being published on the current trends in Erythropoietin. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to Erythropoietin are being carried out. As reported in blood journal the structure, function, and activation of the erythropoietin receptor erythropoietin (EPO) is the principal growth factor E that promotes the viability, proliferation, and differ-entiation of mammalian erythroid progenitor cells, functions that are transduced by the specific cell surface EPO receptor (EPO-R). In contrast to many other hematopoietic growth factors, EPO primarily affects relatively mature erythroid cells, although it may also influence the growth and behavior of other cells. The recent cloning of the EPO-R gene has greatly facilitated the molecular analysis of the structure and function of this receptor, and provided a fundamental link to earlier biochemical and cellular studies of erythropoiesis. Erythropoietin is a very important component for the formation of RBC’s and hence it is of utmost importance for scientists working to seek the latest research work in this field. 

The Journal of Blood Disorders & Transfusion is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals dealing with Erythropoietin. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Blood Disorders & Transfusion provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of Erythropoietin and bioinformatics, thus bridging the gap between researchers and young scientists.

OMICS International – a pioneer in organizing international conferences Journal of Blood Disorders & Transfusion is associated with our "2nd International Conference on Hematology & Blood Disorders" (Hematology-2014) during September 29-October 01, 2014 Baltimore, USA with a theme “On the Path of Identifying Novel Therapeutics for Blood Disorders”.